Why Is REPLIGEN CORP (RGEN) Stock Up Today?

Repligen Corp (RGEN) shares surged 11.68% to $146.37 on Monday, driven by the company's second-quarter 2026 earnings report and revised full-year guidance. The stock opened with a 2.9% gap up and reached an intraday high of $146.95 before settling near that level. The rally followed the release of better-than-expected earnings and revenue results, along with an upward revision to annual financial targets.

What Happened

Repligen reported second-quarter 2026 non-GAAP earnings per share of $0.54, exceeding estimates by $0.09. Revenue for the quarter reached $204.1 million, up by $2.7 million from expectations. The company also updated its full-year 2026 guidance, raising adjusted EPS expectations from $1.97 to $2.05 to a new range of $2.03 to $2.09. It similarly increased sales guidance from $803 million to $833 million to a new range of $813 million to $835 million. The SEC 8-K filing disclosed these results and included updated financial statements. The stock's sharp intraday move reflects strong investor reaction to the improved outlook and performance.

What The Data Shows

The stock opened at $134.90, with volume of 0.1 million shares, which is 0.1 times the 3-month daily average. The session saw a rapid ascent, with the price climbing from the open to a high of $146.95 within an hour. The stock is currently trading near its 52-week high of $175.77. Repligen's fundamentals show a market cap of $7.4 billion, a P/E ratio of 144.0, and trailing 12-month revenue growth of 17.4%. The company's net margin stands at 6.7%. Recent insider transactions include two sales by the CFO totaling $186,000 in the last 90 days.

What To Watch

Repligen has no upcoming earnings date in the near term, but investors should monitor the breadth of analyst coverage and any further updates to its full-year guidance. The stock's volatility and elevated P/E ratio suggest continued sensitivity to earnings and operational performance.